Variable | All patients | Patients with TE < 7.1 kPa | Patients with TE ≥ 7.1 kPa | p-value |
---|---|---|---|---|
Mean age, years | 47 ± 9 | 46.7 ± 9 | 49 ± 9 | 0.20 |
Male gender, n (%) | 159 (79) | 135 (80) | 24 (73) | 0.36 |
Caucasian Ethnicity, n (%) | 190 (94) | 157 (93) | 33 (100) | 0.87 |
CD4 count (cells/μl), mean ± SD | 591 ± 254 | 591 ± 240 | 589 ± 323 | 0.57 |
Estimated duration of HIV infection in years, mean ± SD | 13 ± 7 | 13 ± 7 | 15 ± 6 | 0.70 |
HBV co-infection, n (%) | 18 (9) | 13 (8) | 5 (15) | 0.18 |
HCV co-infection, n (%) | 35 (17) | 16 (10) | 19 (58) | < 0.0001 |
Chronic ALT elevation, n (%) | 55 (27) | 38 (23) | 17 (52) | 0.001 |
Chronic AST elevation, n (%) | 38 (19) | 19 (11) | 19 (58) | < 0.0001 |
Chronic γ-GT elevation, n (%) | 98 (49) | 73 (43) | 25 (76) | 0.001 |
Exposure to cART, n (%) | 179 (89) | 148 (88) | 31 (94) | 0.38 |
   months on NRTI |  |  |  |  |
   mean ± SD | 188 ± 135 | 186 ± 138 | 199 ± 124 | 0.60 |
   months on NNRTI |  |  |  |  |
   mean ± SD | 36 ± 44 | 38 ± 47 | 32 ± 34 | 0.68 |
   months on PI |  |  |  |  |
   mean ± SD | 90 ± 114 | 83 ± 108 | 131 ± 135 | 0.72 |
   Months on d-drugs |  |  |  |  |
   mean ± SD | 32 ± 48 | 27 ± 44 | 55 ± 64 | 0.006 |
BMI (kg/m2), mean ± SD | 23.4 ± 3.0 | 23.2 ± 2.8 | 24.7 ± 3.7 | 0.06 |
HOMA-IR, mean ± SD | 2.4 ± 2.3 | 2.1 ± 1.8 | 3.8 ± 4.0 | 0.006 |
Total serum cholesterol (mg/dl), | Â | Â | Â | Â |
mean ± SD | 203 ± 45 | 209 ± 45 | 176 ± 34 | < 0.0001 |